You are here

Article Text

Article menu
Download PDFPDF
Abstracts accepted for publication
Scleroderma, myositis and related syndromes - etiology, pathogenesis and animal models
AB0152 The rs11792633-t allele of il-33 gene is associated with systemic sclerosis
  1. S. S. Koca1,
  2. Y. Pehlivan2,
  3. M. Kara3,
  4. F. A. Oner4,
  5. N. Yilmaz5,
  6. G. Y. Cetin6,
  7. B. Kisacik2,
  8. M. Ozgen7,
  9. O. N. Pamuk8,
  10. H. Direskeneli4,
  11. M. Sayarlioglu6,
  12. A. M. Onat2
  1. 1Department Of Rheumatology, Faculty Of Medicine, Firat University, Elazig
  2. 2Department Of Rheumatology, Faculty Of Medicine, Gaziantep University, gaziantep
  3. 3Department of Medical Genetics, Faculty of Medicine, Sıtkı Kocman University, Mugla
  4. 4Department Of Rheumatology, Faculty Of Medicine, Marmara University, Istanbul
  5. 5Department Of Rheumatology, Diyarbakir Education and Research Hospital, Diyarbakir
  6. 6Department Of Rheumatology, Faculty Of Medicine, Sutcu Imam University, Kahramanmaras
  7. 7Department Of Rheumatology, Faculty Of Medicine, Inonu University, Malatya
  8. 8Department Of Rheumatology, Faculty Of Medicine, Trakya University, Edirne, Turkey

Abstract

Background Systemic sclerosis (SSc) is a chronic inflammatory disease characterized by widespread fibrosis of the skin and several visceral organs. Its pathogenesis is not fully known. However, T lymphocytes actives fibroblasts directly via CD154/CD40 ligand or indirectly via pro-fibrotic cytokines including interleukin (IL)-4, IL-6 and transforming growth factor (TGF)-β. Therefore, extracellular matrix components such as collagen and fibronectin are produced by active fibroblasts. The pro-fibrotic potential of IL-33 has been demonstrated by in both in vitro and in vivo settings; moreover, increased level of IL-33 has also been reported in patients with SSc.

Objectives The aim of the present study was to detect the potential association of IL-33 gene polymorphisms on the susceptibility of SSc.

Methods 300 SSc patients and 280 healthy controls (HC) from 6 different regions of Turkey were enrolled in this multicentric preliminary candidate gene study. DNA samples were harvested using an appropriate commercial DNA isolation kit. Four single nucleotide polymorphisms (SNPs) of IL-33 gene (rs7044343, rs1157505, rs11792633 and rs1929992) were genotyped using the appropriate commercial primer/probe sets on real-timePCR. Statistical analysis was performed by Chi-square test, and odds ratio (OR) and 95% confidence interval (CI) were determined for alleles. The Tukey-Kramer’s method for multiple testing was used and P values less than 0.0125 were considered as significant.

Results There was no significant difference in terms of the genotypic distributions of evaluated four IL-33 polymorphisms between the SSc and HC groups (p>0.05 for all). Moreover, allelic distributions and MAF of rs7044343, rs1157505, and rs1929992 polymorphism were not significantly different (p>0.05 for all). However, the frequency of rs11792633-T allele was significantly higher in the SSc group compared to the HC group (0.0001, OR: 1.5, % 95 CI: 1.2-1.8).

Conclusions This preliminary candidate gene study demonstrates thatrs11792633-T allele of IL-33 gene is associated with the susceptibility to the SSc in Turkish population. It may be suggested that IL-33 gene may be a candidate gene to research in SSc.

  1. Schmitz J, et al. Immunity. 2005;23:479-90.

  2. Rankin AL, et al. J Immunol. 2010;184(3):1526-35.

  3. Manetti M, et al. Ann Rheum Dis. 2011;70(10):1876-8.

  4. Yanaba K, et al. Clin Rheumatol. 2011;30(6):825-30.

  5. Terras S, et al. Ann Rheum Dis. 2013;72(1):144-5.

Acknowledgements none

Disclosure of Interest None Declared

https://doi.org/10.1136/annrheumdis-2013-eular.2475

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.